Moderna Takes The Lead With Plan To Tackle New COVID-19 Variants

New Tweaked Booster To Enter Phase I Study

 
• By Andrew McConaghie
  
Moderna aims to produce up to 1 billion doses of its existing vaccine in 2021 - but a new booster to target variants will also enter Phase I trials.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anti-infective

More from Therapeutic Category